The Covid-19 vaccine pill by Merck will be available, to entice you into taking their death jab, in case you don’t like needles.
The U.S. is set to Pay $712 Per Patient for Merck’s COVID-19 vaccine pill.
Merck is set to get $712 per treatment course for its COVID-19 vaccine pill from the U.S. government—even as it costs a fraction of that to produce, and is reportedly on track for a price of $12 in India.
$712 per covid treatment per person? Just when you thought it was too late to buy stock in anything Covid, it looks like you have another chance.
Politicians will be lining their pockets with this new covid vaccine in pill form, so why not you? Just kidding. I wouldn’t invest any money to help further their genocide agenda.
Merck filed for emergency use authorization for the Covid-19 vaccine pill from the Food and Drug Administration for its drug this week, after it said an interim analysis of trial data show it cut hospitalizations in COVID-19 patients. An FDA’s advisory panel will consider the covid-19 vaccine pill in November of 2021.
Here we go with the emergency use again. Emergency use for what?
Last I checked, the only people dying were the ones being murdered in hospitals. I’ve been to 5 family funerals in the last 7 weeks, as my readers know.
The covid treatment, a collection of pills given over five days, would be the first of its kind since the plannedemic started.
How stupid do they think we are? I’m sure you know by now that taking a “flu shot” or any other “vaccine” is probably not a good idea. If you think they won’t sneak the death jab serum into any “vaccine”, well, I’m not sure what to tell you.
What Is The Covid Vaccine Pill By Merck
Originally developed by Emory University with U.S. government funding, the covid vaccine drug was licensed by Ridgeback Biotherapeutics last year.
Merck is set to Make Billions Off COVID Pill Molnupiravir
Merck & Co. is set to make billions off molnupiravir, a promising COVID-19 pill, which could change the pandemic, according to Business Insider, South Africa.
The company is expecting to reap billions in revenue while still making the drug affordable to the world.
Molnupiravir became the first COVID-19 pill to succeed in a late-stage study, which halved the risk of hospitalization and death.
Industry analysts expect the company to make about $22 billion in revenue from the drug through 2030. At the same time, the drug could play a key role in curbing the ongoing pandemic.
The company will have to work to make the drug accessible to most people across the world.
Researchers this month pegged the cost of production for the 5-day Covid-19 treatment course for “covid” at $17.74 (pdf) and estimated Merck could make a sustainable amount even if it priced a course as low as $19.99.
Melissa Barber of the Harvard T.H. Chan School of Public Health and Dzintars Gotham of the King’s College Hospital used the cost of the active pharmaceutical ingredient and other numbers to calculate the estimate.
The U.S. government committed last year to obtain 1.2 billion treatment courses if the drug received regulatory clearance. According to a contract (pdf) obtained by Knowledge Ecology International, the cost of each treatment would be $712.
“This price is equal to about 35 times the estimated sustainable generic price,” Barber and Gotham said.
It’s also 46 times as much as Indian manufacturers plan to charge for a generic version, according to Leena Menghaney, the South Asia head of Médecins Sans Frontières Access Campaign.
There is too much going on in the world with censorship, cult masks, fake vaccines, fake viruses, hospitals murdering people and now a covid vaccine jab in pill form. Do you trust these people, these demons who don’t follow the U.S. Constitution?
Why would you take candy from strangers; your parents taught you this lesson years ago.
“The molnupiravir case illustrates why the ‘TRIPS Waiver’ is so urgently needed, which would waive intellectual property for COVID-19 medical tools during the pandemic and would remove legal barriers so that countries the world over could produce versions of these medicines and more lives could be saved,” she said in a statement, referring to a proposal to waive intellectual property rights for COVID-19 vaccines and treatments.
“We set that price before we had any data, so that’s just one contract,” Kartsonis told the Associated Press. “Obviously we’re going to be responsible about this and make this drug as accessible to as many people around the world as we can.”
Merck in a press release Monday said it was “committed to providing timely access to molnupiravir globally, if it is authorized or approved, and plans to implement a tiered pricing approach based on World Bank country income criteria to reflect countries’ relative ability to finance their health response to the pandemic.”
Most people don’t need a treatment. Use Vitamin c, D3, melatonin, aspirin,Quercetin.
Remember, the Demorats said their goal is to reduce the human world population from billions of people to 500 million.
Share your thoughts on The covid-19 vaccine pill by Merck in the comments section below (I’m sure I know what will be said.)
Share this ROTTER News post with others
Subscribe to ROTTER News – Choose weekly or Express emails.
- Weekly email sent Saturday mornings.
- Express email sent out for each post published.
- After signing up to our mailing list, check your email to confirm.
- Your email address is NEVER shared; it’s only used for our mailing list.
RoxyTube.com – YouTube alternative by me
Roxycast.com – FB alternative by me